Combining two unique AI platforms for the discovery of novel therapeutic targets & preclinical validation of synthetic biomolecules to treat AML

• Unité de recherche: INNOSUISSE
• Numéro de projet: 109.188 INT-LS
• Titre du projet anglais: Combining two unique AI platforms for the discovery of novel therapeutic targets & preclinical validation of synthetic biomolecules to treat AML

Mots-clé (Anglais)

Life sciences, Pharmaceuticals, Deep learning, Medtech, Machine learning, Personalised medicine, Artificial/local/extended/networked intelligence

Résumé des résultats (Abstract) (Anglais)

AMPLY Discovery and Nexco Analytics are combining their novel AI-based drug discovery approaches to advance a unique first-in-class platform, which will identify, and triage, novel targets and discover, and validate, new biologic therapeutic candidates to treat AML.